AI assistant
MUSTANG BIO, INC. — Director's Dealing 2021
Oct 21, 2021
35167_dirs_2021-10-21_c1e0934f-5f86-48ae-baaf-0785c42f8844.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2021-10-12
Reporting Person: Achenbach Brian (SVP, Fin. & Corp. Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-12 | COMMON STOCK | S | 4450 | $2.28 | Disposed | 126603 | Direct |
Footnotes
F1: 4,450 shares were sold in connection with the vesting of 14,688 shares on October 10, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2: Represents the weighted average sales price.
F3: Includes restricted share units, which vest over various time periods.